−14.8
Travere Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−186
FY23:
−280
FY24:
−237
FY25:
37.8
Change from FY21 to FY25
millions USD
FY21:
−138
FY22:
−32.6
FY23:
55.8
FY24:
99.3
FY25:
27.9
Change from FY21 to FY25
millions USD
FY21:
232
FY22:
118
FY23:
219
FY24:
139
FY25:
−33.5
millions USD
FY21:
81.0
FY22:
−104
FY23:
−3.51
FY24:
0.36
FY25:
34.5
(positive)
Change from FY21 to FY23
millions USD
FY21:
−19.9
FY22:
−186
FY23:
−281
FY24:
–
FY25:
–
All amounts in millions USD